HEADER HYDROLASE/HYDROLASE INHIBITOR 16-JAN-06 2FP7 TITLE WEST NILE VIRUS NS2B/NS3PROTEASE IN COMPLEX WITH BZ-NLE-LYS-ARG-ARG-H COMPND MOL_ID: 1; COMPND 2 MOLECULE: GENOME POLYPROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NS2B; COMPND 5 EC: 3.4.21.91,3.6.1.15,3.6.4.13,2.1.1.56,2.1.1.57,2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: GENOME POLYPROTEIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: NS3PRO; COMPND 11 EC: 3.4.21.91,3.6.1.15,3.6.4.13,2.1.1.56,2.1.1.57,2.7.7.48; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: N-BENZOYL-L-NORLEUCYL-L-LYSYL-N-[(2S)-5-CARBAMIMIDAMIDO-1- COMPND 15 HYDROXYPENTAN-2-YL]-L-ARGININAMIDE; COMPND 16 CHAIN: C; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: WEST NILE VIRUS; SOURCE 3 ORGANISM_COMMON: WNV; SOURCE 4 ORGANISM_TAXID: 11082; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: WEST NILE VIRUS; SOURCE 12 ORGANISM_COMMON: WNV; SOURCE 13 ORGANISM_TAXID: 11082; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 22 ORGANISM_TAXID: 32630 KEYWDS FLAVIVIRUS, NS3 PROTEASE, NS2B COFACTOR, SUBSTRATE-BASED INHIBITOR, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.SCHIERING,A.D'ARCY,P.ERBEL REVDAT 11 03-APR-24 2FP7 1 REMARK REVDAT 10 15-NOV-23 2FP7 1 LINK ATOM REVDAT 9 14-FEB-18 2FP7 1 REMARK REVDAT 8 18-OCT-17 2FP7 1 REMARK REVDAT 7 28-JUN-17 2FP7 1 SOURCE DBREF REVDAT 6 05-JUN-13 2FP7 1 REVDAT 5 02-NOV-11 2FP7 1 HET HETATM LINK REMARK REVDAT 5 2 1 SEQRES SITE REVDAT 4 13-JUL-11 2FP7 1 VERSN REVDAT 3 24-FEB-09 2FP7 1 VERSN REVDAT 2 06-JUN-06 2FP7 1 JRNL REVDAT 1 07-MAR-06 2FP7 0 JRNL AUTH P.ERBEL,N.SCHIERING,A.D'ARCY,M.RENATUS,M.KROEMER,S.P.LIM, JRNL AUTH 2 Z.YIN,T.H.KELLER,S.G.VASUDEVAN,U.HOMMEL JRNL TITL STRUCTURAL BASIS FOR THE ACTIVATION OF FLAVIVIRAL NS3 JRNL TITL 2 PROTEASES FROM DENGUE AND WEST NILE VIRUS. JRNL REF NAT.STRUCT.MOL.BIOL. V. 13 372 2006 JRNL REFN ISSN 1545-9993 JRNL PMID 16532006 JRNL DOI 10.1038/NSMB1073 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 25216 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1328 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.68 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.72 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1762 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.11 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 30.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.32000 REMARK 3 B22 (A**2) : -1.32000 REMARK 3 B33 (A**2) : 1.98000 REMARK 3 B12 (A**2) : -0.66000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.091 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.096 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.060 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.533 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1523 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2060 ; 1.388 ; 1.969 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 186 ; 6.491 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 66 ;28.996 ;24.848 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 241 ;13.167 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;15.465 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 221 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1161 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 619 ; 0.195 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1026 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 130 ; 0.117 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 28 ; 0.140 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.154 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 944 ; 0.913 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1479 ; 1.485 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 675 ; 2.034 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 580 ; 3.138 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 49 A 88 REMARK 3 ORIGIN FOR THE GROUP (A): 27.9706 51.0938 1.4177 REMARK 3 T TENSOR REMARK 3 T11: -0.1169 T22: -0.1214 REMARK 3 T33: -0.0712 T12: -0.0029 REMARK 3 T13: 0.0601 T23: -0.0108 REMARK 3 L TENSOR REMARK 3 L11: 4.6974 L22: 3.2111 REMARK 3 L33: 1.1726 L12: -1.9451 REMARK 3 L13: 0.3063 L23: -0.7313 REMARK 3 S TENSOR REMARK 3 S11: -0.0410 S12: -0.0386 S13: -0.4780 REMARK 3 S21: 0.0317 S22: 0.1127 S23: 0.4201 REMARK 3 S31: 0.0284 S32: -0.0376 S33: -0.0716 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 19 B 27 REMARK 3 RESIDUE RANGE : B 33 B 168 REMARK 3 ORIGIN FOR THE GROUP (A): 30.6139 50.9406 4.7447 REMARK 3 T TENSOR REMARK 3 T11: -0.0734 T22: -0.0712 REMARK 3 T33: -0.0348 T12: 0.0080 REMARK 3 T13: 0.0462 T23: 0.0052 REMARK 3 L TENSOR REMARK 3 L11: 3.5625 L22: 2.5352 REMARK 3 L33: 0.8569 L12: -1.5622 REMARK 3 L13: 0.0541 L23: -0.1774 REMARK 3 S TENSOR REMARK 3 S11: -0.0847 S12: -0.2318 S13: -0.3470 REMARK 3 S21: 0.1598 S22: 0.0847 S23: 0.1868 REMARK 3 S31: -0.0108 S32: 0.0088 S33: 0.0000 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2FP7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00005 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26547 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 81.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.31300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: INHOUSE - OBTAINED BY SAD PHASING REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 M AMMONIOUM SULFATE, 100MM HEPES., REMARK 280 PH 8.5, VAPOR DIFFUSION, TEMPERATURE 321K, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.62333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 15.81167 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 23.71750 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 7.90583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 39.52917 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-BENZOYL-L-NORLEUCYL-6-AMMONIO-L-NORLEUCYL-N~5~-[AMINO(IMINIO) REMARK 400 METHYL]-N-[(2S)-5-CARBAMIMIDAMIDO-1-HYDROXYPENTAN-2-YL]-L- REMARK 400 ORNITHINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-BENZOYL-L-NORLEUCYL-6-AMMONIO-L-NORLEUCYL-N~5~- REMARK 400 [AMINO(IMINIO)METHYL]-N-[(2S)-5-CARBAMIMIDAMIDO-1- REMARK 400 HYDROXYPENTAN-2-YL]-L-ORNITHINAMIDE REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 44 REMARK 465 SER A 45 REMARK 465 HIS A 46 REMARK 465 MET A 47 REMARK 465 LEU A 48 REMARK 465 ASN A 89 REMARK 465 ASP A 90 REMARK 465 PRO A 91 REMARK 465 GLY A 92 REMARK 465 ALA A 93 REMARK 465 PRO A 94 REMARK 465 TRP A 95 REMARK 465 LYS A 96 REMARK 465 GLY A 97 REMARK 465 GLY B 16 REMARK 465 ASP B 17 REMARK 465 THR B 18 REMARK 465 ARG B 28 REMARK 465 GLY B 29 REMARK 465 LEU B 30 REMARK 465 LEU B 31 REMARK 465 GLY B 32 REMARK 465 MET B 171 REMARK 465 GLU B 172 REMARK 465 GLU B 173 REMARK 465 PRO B 174 REMARK 465 ALA B 175 REMARK 465 PRO B 176 REMARK 465 ALA B 177 REMARK 465 GLY B 178 REMARK 465 PHE B 179 REMARK 465 GLU B 180 REMARK 465 PRO B 181 REMARK 465 GLU B 182 REMARK 465 MET B 183 REMARK 465 LEU B 184 REMARK 465 ARG B 185 REMARK 465 LYS B 186 REMARK 465 LYS B 187 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 135 O OAR C 5 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL B 100 73.97 -101.17 REMARK 500 NLE C 2 -133.92 97.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF N-BENZOYL-L REMARK 800 -NORLEUCYL-L-LYSYL-N-[(2S)-5-CARBAMIMIDAMIDO-1- HYDROXYPENTAN-2- REMARK 800 YL]-L-ARGININAMIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FOM RELATED DB: PDB REMARK 900 DENGUE VIRUS NS2B/NS3 PROTEASE DBREF 2FP7 A 50 96 UNP P06935 POLG_WNV 1420 1466 DBREF 2FP7 B 16 187 UNP P06935 POLG_WNV 1517 1688 DBREF 2FP7 C 1 5 PDB 2FP7 2FP7 1 5 SEQADV 2FP7 GLY A 44 UNP P06935 EXPRESSION TAG SEQADV 2FP7 SER A 45 UNP P06935 EXPRESSION TAG SEQADV 2FP7 HIS A 46 UNP P06935 EXPRESSION TAG SEQADV 2FP7 MET A 47 UNP P06935 EXPRESSION TAG SEQADV 2FP7 LEU A 48 UNP P06935 EXPRESSION TAG SEQADV 2FP7 GLU A 49 UNP P06935 EXPRESSION TAG SEQADV 2FP7 GLY A 97 UNP P06935 EXPRESSION TAG SEQRES 1 A 54 GLY SER HIS MET LEU GLU THR ASP MET TRP ILE GLU ARG SEQRES 2 A 54 THR ALA ASP ILE THR TRP GLU SER ASP ALA GLU ILE THR SEQRES 3 A 54 GLY SER SER GLU ARG VAL ASP VAL ARG LEU ASP ASP ASP SEQRES 4 A 54 GLY ASN PHE GLN LEU MET ASN ASP PRO GLY ALA PRO TRP SEQRES 5 A 54 LYS GLY SEQRES 1 B 172 GLY ASP THR THR THR GLY VAL TYR ARG ILE MET THR ARG SEQRES 2 B 172 GLY LEU LEU GLY SER TYR GLN ALA GLY ALA GLY VAL MET SEQRES 3 B 172 VAL GLU GLY VAL PHE HIS THR LEU TRP HIS THR THR LYS SEQRES 4 B 172 GLY ALA ALA LEU MET SER GLY GLU GLY ARG LEU ASP PRO SEQRES 5 B 172 TYR TRP GLY SER VAL LYS GLU ASP ARG LEU CYS TYR GLY SEQRES 6 B 172 GLY PRO TRP LYS LEU GLN HIS LYS TRP ASN GLY HIS ASP SEQRES 7 B 172 GLU VAL GLN MET ILE VAL VAL GLU PRO GLY LYS ASN VAL SEQRES 8 B 172 LYS ASN VAL GLN THR LYS PRO GLY VAL PHE LYS THR PRO SEQRES 9 B 172 GLU GLY GLU ILE GLY ALA VAL THR LEU ASP TYR PRO THR SEQRES 10 B 172 GLY THR SER GLY SER PRO ILE VAL ASP LYS ASN GLY ASP SEQRES 11 B 172 VAL ILE GLY LEU TYR GLY ASN GLY VAL ILE MET PRO ASN SEQRES 12 B 172 GLY SER TYR ILE SER ALA ILE VAL GLN GLY GLU ARG MET SEQRES 13 B 172 GLU GLU PRO ALA PRO ALA GLY PHE GLU PRO GLU MET LEU SEQRES 14 B 172 ARG LYS LYS SEQRES 1 C 5 BEZ NLE LYS ARG OAR MODRES 2FP7 NLE C 2 LEU NORLEUCINE MODRES 2FP7 OAR C 5 ARG N-(4-AMINO-5-HYDROXY-PENTYL)-GUANIDINE HET BEZ C 1 8 HET NLE C 2 8 HET OAR C 5 11 HETNAM BEZ BENZOIC ACID HETNAM NLE NORLEUCINE HETNAM OAR N-(4-AMINO-5-HYDROXY-PENTYL)-GUANIDINE FORMUL 3 BEZ C7 H6 O2 FORMUL 3 NLE C6 H13 N O2 FORMUL 3 OAR C6 H16 N4 O FORMUL 4 HOH *133(H2 O) HELIX 1 1 TRP B 50 LYS B 54 1 5 HELIX 2 2 PRO B 131 SER B 135 5 5 SHEET 1 A 6 TRP A 53 ALA A 58 0 SHEET 2 A 6 GLY B 21 MET B 26 -1 O VAL B 22 N ALA A 58 SHEET 3 A 6 GLN B 35 VAL B 42 -1 O GLY B 37 N ILE B 25 SHEET 4 A 6 VAL B 45 LEU B 49 -1 O HIS B 47 N VAL B 40 SHEET 5 A 6 ARG B 76 TYR B 79 -1 O LEU B 77 N THR B 48 SHEET 6 A 6 PRO B 67 SER B 71 -1 N TYR B 68 O CYS B 78 SHEET 1 B 5 GLU A 67 ILE A 68 0 SHEET 2 B 5 LYS B 107 THR B 111 1 O GLN B 110 N GLU A 67 SHEET 3 B 5 VAL B 95 VAL B 99 -1 N VAL B 95 O THR B 111 SHEET 4 B 5 PRO B 138 VAL B 140 -1 O VAL B 140 N GLN B 96 SHEET 5 B 5 VAL B 146 LEU B 149 -1 O GLY B 148 N ILE B 139 SHEET 1 C 6 PHE A 85 LEU A 87 0 SHEET 2 C 6 ARG A 74 LEU A 79 -1 N ARG A 78 O GLN A 86 SHEET 3 C 6 GLY B 114 THR B 118 1 O LYS B 117 N VAL A 75 SHEET 4 C 6 GLY B 121 VAL B 126 -1 O ALA B 125 N GLY B 114 SHEET 5 C 6 TYR B 161 ALA B 164 -1 O SER B 163 N VAL B 126 SHEET 6 C 6 GLY B 153 ILE B 155 -1 N VAL B 154 O ILE B 162 SHEET 1 D 2 LEU B 58 SER B 60 0 SHEET 2 D 2 GLY B 63 LEU B 65 -1 O LEU B 65 N LEU B 58 LINK OG SER B 135 C OAR C 5 1555 1555 1.36 LINK C BEZ C 1 N NLE C 2 1555 1555 1.26 LINK C NLE C 2 N LYS C 3 1555 1555 1.27 LINK C ARG C 4 N OAR C 5 1555 1555 1.34 SITE 1 AC1 26 ASP A 82 GLY A 83 ASN A 84 PHE A 85 SITE 2 AC1 26 GLN A 86 HIS B 51 PRO B 67 TYR B 68 SITE 3 AC1 26 TRP B 69 GLY B 70 VAL B 72 ASP B 75 SITE 4 AC1 26 ASP B 129 TYR B 130 THR B 132 SER B 135 SITE 5 AC1 26 GLY B 151 ASN B 152 GLY B 153 TYR B 161 SITE 6 AC1 26 HOH B1020 HOH B1043 HOH B1045 HOH B1059 SITE 7 AC1 26 HOH B1066 HOH B1078 CRYST1 93.425 93.425 47.435 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010704 0.006180 0.000000 0.00000 SCALE2 0.000000 0.012360 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021081 0.00000